Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Akero Therapeutics, Inc. (AKRO) had Debt to Capital Ratio of 0.02 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-70.50M |
|
-- |
|
-- |
|
$80.87M |
|
$-80.87M |
|
$10.37M |
|
$-70.50M |
|
$-70.50M |
|
$-70.50M |
|
$-70.50M |
|
$-70.50M |
|
$-70.50M |
|
$-80.87M |
|
$-83.55M |
|
81.72M |
|
81.72M |
|
$-0.86 |
|
$-0.86 |
|
| Balance Sheet Financials | |
$764.60M |
|
-- |
|
$344.55M |
|
$1.11B |
|
$60.40M |
|
$22.56M |
|
$22.93M |
|
$83.33M |
|
$1.03B |
|
$1.03B |
|
$1.03B |
|
79.92M |
|
| Cash Flow Statement Financials | |
$-115.91M |
|
$-402.84M |
|
$398.96M |
|
$340.24M |
|
$220.45M |
|
$-119.79M |
|
$17.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.66 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.02 |
0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-115.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.87% |
|
-6.87% |
|
-6.36% |
|
-6.73% |
|
$12.84 |
|
$-1.42 |
|
$-1.42 |
|